- Home
- CRDF vs FTLF Comparison
CRDF vs FTLF Comparison
Compare CRDF & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- FTLF
- Stock Information
- Founded
- CRDF 1999
- FTLF 2005
- Country
- CRDF United States
- FTLF United States
- Employees
- CRDF N/A
- FTLF N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- FTLF Medicinal Chemicals and Botanical Products
- Sector
- CRDF Health Care
- FTLF Health Care
- Exchange
- CRDF Nasdaq
- FTLF Nasdaq
- Market Cap
- CRDF 144.4M
- FTLF 149.3M
- IPO Year
- CRDF N/A
- FTLF N/A
- Fundamental
- Price
- CRDF $2.05
- FTLF $17.64
- Analyst Decision
- CRDF Strong Buy
- FTLF Strong Buy
- Analyst Count
- CRDF 5
- FTLF 2
- Target Price
- CRDF $11.10
- FTLF $23.00
- AVG Volume (30 Days)
- CRDF 1.1M
- FTLF 13.6K
- Earning Date
- CRDF 11-06-2025
- FTLF 08-14-2025
- Dividend Yield
- CRDF N/A
- FTLF N/A
- EPS Growth
- CRDF N/A
- FTLF N/A
- EPS
- CRDF N/A
- FTLF 0.80
- Revenue
- CRDF $545,000.00
- FTLF $63,053,000.00
- Revenue This Year
- CRDF N/A
- FTLF $19.26
- Revenue Next Year
- CRDF N/A
- FTLF $31.61
- P/E Ratio
- CRDF N/A
- FTLF $22.66
- Revenue Growth
- CRDF N/A
- FTLF 3.91
- 52 Week Low
- CRDF $1.90
- FTLF $9.83
- 52 Week High
- CRDF $5.64
- FTLF $19.20
- Technical
- Relative Strength Index (RSI)
- CRDF 36.50
- FTLF 53.48
- Support Level
- CRDF $2.03
- FTLF $18.25
- Resistance Level
- CRDF $2.27
- FTLF $19.18
- Average True Range (ATR)
- CRDF 0.12
- FTLF 0.84
- MACD
- CRDF 0.04
- FTLF -0.17
- Stochastic Oscillator
- CRDF 31.91
- FTLF 29.73
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.